Biostar Pharmaceuticals, Inc.  BSPM
 Performance   more  
Growth of $10,00005-01-13
Total Return%201020112012YTD
 Stock-36.6-78.0-46.2-16.0
 +/- Industry-39.9-93.6-61.5-34.3
 +/- S&P 500-49.4-78.0-59.6-27.0
 
 Key Stats   
Last Close (05-01-13)$.84
Market Cap $Mil17
Sales $Mil92
Morningstar Style Box Small Value
Industry Drug Manufacturers - Major
Sector Healthcare
Stock Type  Distressed
Morningstar Stock Grades
Growth A
Profitability C
Financial Health D
 Valuation   more  04-23-12 
StockIndustryS&P 500
Price/Earnings1.414.715.2
Forward P/E------13.4
Price/Book0.22.62.0
Price/Cash Flow1.99.97.1
Price/Sales0.22.41.2
Dividend Yield %------2.0
S&P 500 data through 04-23-12
 Growth   more  12-31-11 
1 Year%
3 Year%
S&P 500
Sales14.639.58.2
Net Income-30.022.112.6
EPS-30.226.013.1
Equity/Share22.737.111.5
Dividends------3.9
S&P 500 data - 3 Year%
 Profitability   more  12-31-11 
StockIndustryS&P 500
ROA %16.17.89.4
ROE %17.816.822.6
  Net Margin %13.215.213.9
  Asset Turnover1.20.50.8
  Fin Leverage1.13.16.1
Sales/Employee
$Thousands		182.5------
Stock uses trailing 12 months. Industry and S&P 500 use fiscal year-end.
 Earnings Trends   more  12-31-11 
Historical years use fiscal year-end.
 Fund Ownership  more  
 % Shares Held % Fund Assets Star Rating
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2013 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.














More National News


Most Popular Stories